Europe Menopausal Disorder Treatment Market – Industry Trends and Forecast to 2030

Europe Menopausal disorder Treatment Market Analysis and Size

In the recent years, the market is estimated to grow rapidly during the forecast period. Menopause is one of the most physically demanding times in any women’s life, encouraging pharmaceutical companies globally to create effective medications to treat it and its associated problems. Menopausal problems are becoming more prevalent in all parts of the world, and several healthcare organizations support developing and using medications that can effectively treat them.

Data Bridge Market Research analyses a growth rate in the menopausal disorder treatment market in the forecast period 2023-2030. The expected CAGR of menopausal disorder treatment market is tend to be around 6.5% in the mentioned forecast period. The market was valued at USD 3.3 billion in 2022, and it would grow upto USD 5.46 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Europe Menopausal disorder Treatment Market Scope and Segmentation

Market Definition

Menopause is a natural biological process that occurs because of the reduction of reproductive hormones. This marks the end of the menstrual cycle. It generally occurs in the age of late 40s or 50s. The menopause symptoms are different for every women. Every woman experiences these menopause symptoms in a different way. Estrogen levels decline throughout menopause. These signs and symptoms include night sweats, vaginal dryness, hot flashes, abnormal menstrual cycles, difficulty sleeping, mood swings, and others.

Menopausal Disorder Treatment Market Dynamics

Drivers

• Increased Drug Development Processes

A rise in the number of menopausal drugs in the drug development pipeline of numerous key manufacturers is one of the biggest market growth opportunities. It includes specific and innovative drugs, that focus on decreasing side effects and providing improved efficacy. For instance, Fuji Pharma Co., Ltd. has a natural progesterone drug (FSN-011-01) in its pipeline, and has submitted an application for marketing approval of the same to the Ministry of Health, Labour and Welfare, Japan.

• Higher Demand of Herbal Treatments

With each passing decade, women are drifting more towards herbal supplements as a menopause treatment which is one of the market's most prominent latest developments. As a result, several companies are responding to the market need by manufacturing new products which contain menopause-relieving components. For instance, black cohosh and soy isoflavones are the two natural remedies that worked well for menopause.

Opportunities

• Major Impact of Trending Lifestyle and Stress

In recent years, it has become favourably important to provide women with much effective therapy for menopause symptoms due to the rise in the incidence of physical and mental health issues among women. Factors such as hot flashes, migraine, anxiety, formication, fatigue, mood swings, irritability, and insomnia, contribute a lot to many companies to develop cutting-edge therapies to improve these symptoms. Immense growth in the menopause therapy industry is being supported by extensive investments in extended R&D initiatives to launch novel medications.

• Rising Demand of Oral Drugs

Oral drugs are one of the easiest, most durable, most affordable, and portable. It has been seen that the rate of contamination is also the least. This makes this route of administration more beneficial. The oral mode of administration is found to be the most accessible, cost-effective, and extensively used mode of medication administration.

Restraints/Challenges

• Increasing Underlying Disparities Between Genders

Several companies providing multiple treatments for menopause have struggled significantly due to the widespread existence of major gender-wise health disparities in many of the nations. Women in nations with restricted awareness and income see no gains in their health because of the lack of adequate healthcare infrastructure. This acts as a major restriction for the market.  

• Side Effects of Hormone Therapy

As per the FDA, various complications associated with hormone therapy carry numerous hazards, including the possibility of stroke, heart problems, blood clots, and breast cancer. Thus, it hampers the market growth.   

This menopausal disorder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the menopausal disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Europe Menopausal disorder Treatment Market

The menopausal disorder treatment market is segmented on the basis of stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Stages

• Menopause
• Postmenopause
• Perimenopause

Type

• Hormonal Therapy
• Non-Hormonal Therapy

Menopause Symptoms

• Vasomotor Symptoms
• Atrophic Vaginitis
• Osteoporosis
• Joint Pain
• Weight Gain
• Dyspareunia
• Depression
• Others

Dosage Form

• Tablet
• Cream

• Gels
• Rings/Insert
• Patch/Film
• Injection Shot
• Spray
• Others

Route of Administration

• Oral
• Vaginal
• Transdermal
• Parenteral

End User

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Other

Europe Menopausal Disorder Treatment Market Regional Analysis/Insights

The menopausal disorder treatment market is analyzed and market size insights and trends are provided by stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel as referenced above.

The major countries covered in the menopausal disorder treatment market report are U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Belgium  .

Europe dominates the menopausal disorder treatment market because of rising introduction of novel drugs by several key players.

Germany is dominating the menopausal disorder treatment market due to the growing demand of many effective treatments such as hormone replacement therapy.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Europe Menopausal Disorder Treatment Market Share Analysis

The menopausal disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to menopausal disorder treatment market

Key players operating in the menopausal disorder treatment market t include:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France), Pfizer Inc. (U.S.)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Merck & Co., Inc. (U.S.)
• Eli Lilly and Company (U.S.)
• Abbott (U.S.)
• Novo Nordisk A/S (Denmark)
• Abbvie, Inc (U.S.)
• Dr. Reddy’s Laboratories Ltd. (India)
• TherapeuticsMD, Inc. (U.S.)
• Ipsen Pharma (France)
• Besins Healthcare (Belgium)
• Mithra Pharmaceuticals (Belgium)
• Aché Laboratórios Farmacêuticos S.A (Brazil)
• SEBELA PHARMACEUTICALS (U.S.)
• Fervent Pharmaceuticals Inc. (U.S.)
• KaNDy Therapeutics (U.K.)
• Duchesnay (U.S.) 

SKU-56617